Galapagos to present at upcoming investor conferences

On August 24, 2022 Galapagos NV (Euronext & NASDAQ: GLPG) reported that management will participate in the following upcoming investor conferences (Press release, Galapagos, AUG 24, 2022, View Source [SID1234618620]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 17th Annual Biopharma Conference. September 8, 2022 in Boston
Morgan Stanley 20th Global Healthcare Conference. September 12-14, 2022 in New York
Bank of America Merrill Lynch Global Healthcare Conference. September 15, 2022 in London
KBC Securities Virtual Life Sciences Conference. September 16, 2022
JP Morgan CEO Call Series. September 28, 2022
Credit Suisse 31st Annual Healthcare Conference. November 8-10, 2022 in Rancho Palos Verdes, CA
Bryan Garnier Virtual Conference on Cell Therapy Innovation. November 14, 2022
Jefferies 2022 Global Healthcare Conference. November 16-17, 2022 in London
Kepler Cheuvreux Virtual Life Science Days. November 21, 2022
Deutsche Bank 2022 Call Series. November 30, 2022

Additional information regarding these events will be available on the investor section of the Galapagos website at glpg.com/events.